Astellas Pharma Inc. - Net Worth and Insider Trading
Astellas Pharma Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Astellas Pharma Inc. owns 3 companies in total, including FibroGen Inc (FGEN) , Sucampo Pharmaceuticals Inc (SCMP) , and Taysha Gene Therapies Inc (TSHA) .
Click here to see the complete history of Astellas Pharma Inc.’s form 4 insider trades.
Insider Ownership Summary of Astellas Pharma Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FGEN | FibroGen Inc | 2014-11-13 | 10 percent owner |
SCMP | Sucampo Pharmaceuticals Inc | 2007-08-07 | other: Former 10% Owner |
TSHA | Taysha Gene Therapies Inc | 2022-10-21 | 10 percent owner |
Astellas Pharma Inc. Trading Performance
Astellas Pharma Inc. Ownership Network
Ownership Network List of Astellas Pharma Inc.
Ownership Network Relation of Astellas Pharma Inc.

Astellas Pharma Inc. Owned Company Details
What does FibroGen Inc do?
Who are the key executives at FibroGen Inc?
Astellas Pharma Inc. is the 10 percent owner of FibroGen Inc. Other key executives at FibroGen Inc include Chief Commercial Officer Thane Wettig , director & Chief Executive Officer Enrique A Conterno , and SVP & China Operations Christine Chung .
FibroGen Inc (FGEN) Insider Trades Summary
Over the past 18 months, Astellas Pharma Inc. made no insider transaction in FibroGen Inc (FGEN). Other recent insider transactions involving FibroGen Inc (FGEN) include a net purchase of 195,000 shares made by Thane Wettig , a net purchase of 300,000 shares made by James A Schoeneck , and a net purchase of 22,123 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 445,000 shares, with a net purchase of 445,000 shares. During the past 18 months, 0 shares of FibroGen Inc (FGEN) were sold and 517,123 shares were bought by its insiders, resulting in a net purchase of 517,123 shares.
FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
FibroGen Inc Insider Transactions
Astellas Pharma Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Astellas Pharma Inc.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Astellas Pharma Inc.'s mailing address is: Tokyo M0 103-8411.